Skip to main content

Table 5 Clinicopathological features of T3 EL (−), T3 ELI (+), and T3 ELI (−)

From: Prognostic value of elastic lamina staining in patients with stage III colon cancer

Features

T3 EL (−)

T3 ELI (+)

T3 ELI (−)

P

Age (years) Median (range)

63 (35–85)

62 (43–78)

62 (50–76)

0.615

Sex

 Male

14 (53.8%)

5 (41.7%)

8 (47.1%)

0.768

 Female

12 (46.2%)

7 (58.3%)

9 (52.9%)

 

Tumor location

 Cecum

1 (3.8%)

1 (8.3%)

0 (0%)

0.13

 Ascending

4 (15.4%)

3 (25%)

6 (35.3%)

 

 Hepatic flexure

1 (3.8%)

0 (0%)

4 (23.5%)

 

 Transverse

3 (11.5%)

0 (0%)

0 (0%)

 

 Splenic flexure

1 (3.8%)

0 (0%)

2 (11.8%)

 

 Descending

2 (7.7%)

2 (16.7%)

1 (5.9%)

 

 Sigmoid

14 (53.8%)

6 (50%)

4 (23.5%)

 

Location

 Right-sided colon

8 (30.8%)

4 (33.3%)

10 (58.8%)

0.161

 Left-sided colon

18 (69.2%)

8 (66.7%)

7 (41.2%)

 

N stage

 N1

22 (84.6%)

6 (50%)

16 (94.1%)

0.01

 N2

4 (15.4%)

6 (50%)

1 (5.9%)

 

Pathology type

 Adenocarcinoma

18 (69.2%)

7 (58.3%)

15 (88.2%)

0.174

 Mucinous adenocarcinoma

8 (30.8%)

5 (41.7%)

2 (11.8%)

 

Tumor differentiation

 Well

6 (23.1%)

1 (8.3%)

2 (11.8%)

0.656

 Moderate

18 (69.2%)

9 (75%)

12 (70.6%)

 

 Poorly to undifferentiated

2 (7.7%)

2 (16.7%)

3 (17.6%)

 

Tumor grade

 High

2 (7.7%)

2 (16.7%)

3 (17.6%)

0.568

 Low

24 (92.3%)

10 (83.3%)

14 (82.4%)

 

Lymphovascular invasion

 Present

0 (0%)

2 (16.7%)

2 (11.8%)

0.128

 Absent

26 (100%)

10 (83.3%)

15 (88.2%)

 

PNI

 Present

0 (0%)

1 (8.3%)

1 (5.9%)

0.371

 Absent

26 (100%)

11 (91.7%)

16 (94.1%)

 

EMVI

 Positive

2 (7.7%)

3 (25%)

1 (5.9%)

0.205

 Negative

24 (92.3%)

9 (75%)

16 (94.1%)